CCIA
MNTA

Campbell & Co Investment Adviser’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Campbell & Co Investment Adviser’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-45,887
Closed -$753K – 290
2015
Q3 		$753K Buy
+45,887
New +$939K 0.5% 50
2014
Q2 		– Sell
-15,130
Closed -$176K – 268
2014
Q1 		$176K Buy
+15,130
New +$256K 0.07% 192

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Campbell & Co Investment Adviser's MNTA Position: Q4 2015 in Review

Campbell & Co Investment Adviser sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2015, closing a stake of 45,887 shares — an estimated $753K sold.

Campbell & Co Investment Adviser first reported a position in MNTA in Q1 2014 and held it in 2 quarters. The position peaked at $753K in Q3 2015. 164 funds tracked by Wall St. Rank hold MNTA as of Q4 2015.

  • Campbell & Co Investment Adviser reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 45,887 Momenta Pharmaceuticals, Inc. shares in Q4 2015, an estimated $753K.
  • Campbell & Co Investment Adviser first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
  • Campbell & Co Investment Adviser's Momenta Pharmaceuticals, Inc. position peaked at $753K in Q3 2015.
  • 164 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2015.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2015, filed 16 Feb 2016.